Farnesyltransferase Haplodeficiency Reduces Neuropathology and Rescues Cognitive Function in a Mouse Model of Alzheimer Disease

• Background: Protein prenylation may play an important role in Alzheimer disease. Results: Haplodeficiency in farnesyltransferase and geranylgeranyltransferase-1 attenuates neuropathology, but only reduction of farnesyltransferase rescues cognitive function in Alzheimer mice. Conclusion: Protein farnesylation and geranylgeranylation differentially affect the course of Alzheimer disease. Significance: Specific inhibition of protein farnesylation might be a potential strategy for effectively treating Alzheimer disease. Isoprenoids and prenylated proteins have been implicated in the pathophysiology of Alzheimer disease (AD), including amyloid- precursor protein metabolism, Tau phosphorylation, synaptic plasticity, and neuroinflammation. However, little is known about the relative importance of the two protein prenyltransferases, farnesyltransferase (FT) and geranylgeranyltransferase-1 (GGT), in the pathogenesis of AD. In this study, we defined the impact of deleting one copy of FT or GGT on the development of amyloid- (A)-associated neuropathology and learning/memory impairments in APPPS1 double transgenic mice, a well established model of AD. Heterozygous deletion of FT reduced A deposition and neuroinflammation and rescued spatial learning and memory function in APPPS1 mice. Heterozygous deletion of GGT reduced the levels of A and neuroinflammation but had no impact on learning and memory. These results document that farnesylation and geranylgeranylation play differential roles in AD pathogenesis and suggest that specific inhibition of protein farnesylation could be a potential strategy for effectively treating AD.

Ämnesord

NATURVETENSKAP  -- Biologi -- Biokemi och molekylärbiologi (hsv//swe)

NATURAL SCIENCES  -- Biological Sciences -- Biochemistry and Molecular Biology (hsv//eng)

Nyckelord

Alzheimers Disease

Amyloid

Isoprenoid

Neuroinflammation

Transgenic Mice

Learning and

amyloid precursor protein

long-term potentiation

a-beta

neurofibromatosis type-1

reductase inhibitors

neuronal plasticity

gamma-secretase

h-ras

isoprenoids

deficits

Publikations- och innehållstyp

ref (ämneskategori)

art (ämneskategori)